Interferon treatment with or without oral ganciclovir in HBeAg-negative chronic hepatitis B: a randomized study.
- 1 May 2000
- journal article
- clinical trial
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 7 (3) , 235-240
- https://doi.org/10.1046/j.1365-2893.2000.00220.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lamivudine and intron a combination treatment in patients with chronic hepatitis B infectionJournal of Hepatology, 1998
- A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serumHepatology, 1997
- Ganciclovir treatment of hepatitis B virus infection in liver transplant recipientsHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Antiviral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatmentJournal of Hepatology, 1995
- Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferonJournal of Hepatology, 1992
- Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type BJournal of Hepatology, 1990
- Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigenHepatology, 1989
- Long-term follow-up of anti-HBe-positive chronic active hepatitis BHepatology, 1988